Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP866493.RAOUqg0-KbVvs0fvLMt3Zm2Cwn7A-QpVrkWqKU3svaw1c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP866493.RAOUqg0-KbVvs0fvLMt3Zm2Cwn7A-QpVrkWqKU3svaw1c130_assertion type Assertion NP866493.RAOUqg0-KbVvs0fvLMt3Zm2Cwn7A-QpVrkWqKU3svaw1c130_head.
- NP866493.RAOUqg0-KbVvs0fvLMt3Zm2Cwn7A-QpVrkWqKU3svaw1c130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866493.RAOUqg0-KbVvs0fvLMt3Zm2Cwn7A-QpVrkWqKU3svaw1c130_provenance.
- NP866493.RAOUqg0-KbVvs0fvLMt3Zm2Cwn7A-QpVrkWqKU3svaw1c130_assertion evidence source_evidence_literature NP866493.RAOUqg0-KbVvs0fvLMt3Zm2Cwn7A-QpVrkWqKU3svaw1c130_provenance.
- NP866493.RAOUqg0-KbVvs0fvLMt3Zm2Cwn7A-QpVrkWqKU3svaw1c130_assertion SIO_000772 23546520 NP866493.RAOUqg0-KbVvs0fvLMt3Zm2Cwn7A-QpVrkWqKU3svaw1c130_provenance.
- NP866493.RAOUqg0-KbVvs0fvLMt3Zm2Cwn7A-QpVrkWqKU3svaw1c130_assertion wasDerivedFrom befree-20140225 NP866493.RAOUqg0-KbVvs0fvLMt3Zm2Cwn7A-QpVrkWqKU3svaw1c130_provenance.
- NP866493.RAOUqg0-KbVvs0fvLMt3Zm2Cwn7A-QpVrkWqKU3svaw1c130_assertion wasGeneratedBy ECO_0000203 NP866493.RAOUqg0-KbVvs0fvLMt3Zm2Cwn7A-QpVrkWqKU3svaw1c130_provenance.